Información del artículo
RESUMEN
Pacientes pediátricos con diabetes mellitus son manejados durante el periodo perioperatorio por anestesiólogos pediátricos, quienes monitorean muy cuidadosamente no solo los niveles de glicemia, sino también el tipo de cirugía a realizarse y la fisiopatología de la enfermedad. Este artículo presenta una guía práctica; un algoritmo para el manejo de pacientes pediátricos con diabetes mellitus sometidos a un acto quirúrgico, ya sea con anestesia general o regional.
Keywords:
Diabetes Mellitus, Patients
Post-operative Period
Pediatrics. (Source: MeSH, NLM)
Palabras claves:
Diabetes Mellitus
Pacientes
Periodo Postoperatorio
Pediatría. (Fuente: DeCS, BIREME)
SUMMARY
Pediatric patients with diabetes mellitus are managed during the perioperative period by pediatric anesthesiologist who carefully monitors glycemia levels, in addition to the type of surgery and the pathophysiology of the disease. This article represents a practical guide, an algorithm for managingpediatric diabeticpatients undergoing surgery, whether under general or regional anesthesia.
El Texto completo está disponible en PDF
REFERENCES
[1.]
C.J.H. Kelnar.
The historic background.
EN: Childhood and Adolescent Diabetes, pp. 123
[2.]
J. Jaramillo, G. Reyes, J. Gómez.
Consideraciones generales y anestésicas de algunas enfermedades endocrinas en niños.
Anestesiología Pediátrica, pp. 684-699
[3.]
P. Onkamo, S. Vaananem, M. Karvonen, J. Tuomilehto.
Worldwide increase in incidence of type I diabetes. The analysis of the data on published incidence trends.
Diabetología, 42 (1999), pp. 1395-1403
[4.]
G.R. McAunulty, H.J. Robertshaw, G.M. May.
Anaesthetic manegement of patients with diabetes mellitus.
Br J Anaesth, 85 (2000), pp. 80
[5.]
V. Chadwick, K.A. Wilkinson.
Diabetes mellitus and the pediactic anesthetist.
Pediatr Anaesth, 14 (2004), pp. 716-723
[6.]
R.M. Kirschner.
Diabetes in pediatric ambulatory surgical patients.
J Post Anesth Nurs, 8 (1993), pp. 322-326
[7.]
S.M. Holvey.
Surgery in the child with diabetes.
Pediatr Clin North Am, 16 (1969), pp. 671-679
[8.]
F.R. Kaufman, S. Devgan, T.F. Roe, G. Costil.
Perioperatve manegement with prolonged intravenous insulin infusion versus subcutaneous insulin in children with type I diabetes mellitus.
J Diabetes complications, 10 (1996), pp. 6-11
[9.]
E.T. Rhodes, L.R. Ferrari, J.I. Wolfsdorf.
Perioperative Management of Pediatric Surgical Patients with Diabetes Mellitus.
Anest Analg, 101 (2005), pp. 986-999
[10.]
American Diabetes Association.
Diagnosis and classification of diabetes mellitus.
Diabetes Care, 27 (2004), pp. 5-10
[11.]
M.D. Stoelting, S.T. Dierdorf.
Handbook for Anesthesia an Co-Exisiting Disease.
En: Endocrine Diseases, pp. 301-332
[12.]
M. Nicolino, P. Chatelain.
Diabetes mellitus infantil: clasificación, diagnóstico, epidemiología y etiología.
En: Pombo M. Tratado de Endocrinología Pediátrica., 64 (2002), pp. 1122-1131
[13.]
M. Karvonen, M. Viik-Kajander, E. Moltchanova, I. Libman, R. LaPorte, J. Tuomilehto.
Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group.
Diabetes Care, 23 (2000), pp. 1516-1526
[14.]
A. Fagot-Campagna, D.J. Pettitt, M.M. Englelgau, N.R. Burrows, L.S. Geiss, R. Valdez.
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.
J Pediatr, 136 (2000), pp. 664-672
[15.]
A. Fagot-ampagna, J.B. Saaddine, K.M. Flegal, G.L. Beckles.
Diabetes, impared fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey.
Diabetes Care, 24 (2001), pp. 834-837
[16.]
Tomado de la ficha técnica del medicamento. Disponible en la página web de Sanafi-Aventis: URL: http://www.facmed.unam.mx/bmnd/plm_2k8/src/prods/35539.htm.
[17.]
N.P. Murphy, S.M. Keane, K.K. Ong, M. Ford, J.A. Edge, C.L. Acerini.
Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insuline regimens.
Diabetes Care, 26 (2003), pp. 799-804
[18.]
N. Weintrob, H. Benzaquen, A. Galatzer, S. Shalitin, L. Lazar, G. Fayman.
Comparison of continuos subcutaneous insulin infusión and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
Pediactrics, 112 (2003), pp. 559-564
[19.]
S.M. Willi, J. Planton, L. Egede, S. Schwarz.
Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
J Pediatr, 143 (2003), pp. 796-801
[20.]
E. Codner, V. Meriq, R. Román, I. Hrlic, A. Martínez, N. Unanue.
Nuevos esquemas de tratamiento con insulina en niños y adolescentes con diabetes mellitus tipo 1 en un hospital público.
Rev chil pediatr, 75 (2004), pp. 520-529
[21.]
S. Gahagan, J. Silverstein.
Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska native children: American Academy of Pediatrics Committee on Native American Child Health.
Pediatrics, 112 (2003), pp. e328
[22.]
R. Rapaprt, J.H. Silverstein, L. Garzarella, A.L. Rosenbloom.
Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric endocrinologists.
J Pediatr Endocrinol Metab, 17 (2004), pp. 871-877
[23.]
O. Velazquez, A. Lara, R. Tapia.
Metformina y síndrome metabólico.
Manual de uso, Secretaría de Salud, (2001),
[24.]
F. Contreras, B. Romero, N. Suárez, M. González, C. Fouillioux, E. Guevara, M.C. Betancourt, D. Torres, M. Velasco.
Receptores Sur y Sulfonilureas en el tratamiento de la Diabetes Mellitus Tipo 2.
AVFT., 21 (2002 Jul), pp. 148
[25.]
S. Hernández-Jiménez, C. Aguilar-Salinas, F. Gómez-Pérez, Tiazolidinedionas.
Beneficios y riesgos reales.
Rev Edocrinol Nutr, 10 (2002 Apr-Jun), pp. 69-76
[26.]
H. Yki-Jarvinen.
Thiazolidinediones.
N Engl J Med., 351 (2004 Sep 9), pp. 1106-1118
[27.]
P. Brubaker.
Incretin-based therapies: mimetics versus protease inhibitors.
Trends in Endocrinology and Metabolism., 18 (2007), pp. 240-245
[28.]
Tomada de la ficha técnica del medicamento Disponible en la página web de la Agencia Europea del Medicamento (EMEA http://www.emea.europa.eu/
[29.]
F. Holleman, J.B.L. Hoekstra.
Insulin Lispro.
N Engl J Med, 183 (1997), pp. 176-183
[30.]
S.P. Allison, P.J. Tomlin, M.J. Chamberlain.
Some effects of anesthesia and surgery carbohydrate and fat metabolism.
Br J Anesth, 41 (1969), pp. 588-593
[31.]
J.B. Halter, A.F. Plug.
Relationship of impares insulin secretion during surgical stress to anesthesia and catecholamine release.
J Clin Endocrinol Metaol, 51 (1980), pp. 1093-1098
[32.]
B.R. Hirsh, H. Shamoon.
Defective epinephrine and growth hormone responses in type I diabetes ara stimulus specifica.
Diabetes, 36 (1987), pp. 20-26
[33.]
I.B. Hirsch, J.B. MacGill.
Role of insulin in the manegement of surgical patients with diabetes mellitus.
Diabetes Care, 13 (1990), pp. 980-991
[34.]
C.R. MacKenzie, M.E. Charlson.
Assesment of perioperative risk in the patient with diabetes mellitus.
Surg Gynecol Obstet, 167 (1988), pp. 293-299
[35.]
B.C. Glister, R.A. Vigersky.
Perioperative management of type 1 diabetes mellitus.
Endocrinol Metab Clin North Am, 32 (2003), pp. 411-436
[36.]
G. Van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, M. Schetz.
Intensive insulin theraphy in the critically ill patients.
N Engl J Med, 345 (2001), pp. 1359-1367
[37.]
J.S. Krinsley.
Effect of an intensive glucose management protocol on the mortality of critically ill adult patient.
Mayo Clin Proc, 79 (2004), pp. 992-1000
[38.]
C.S. Rosenberg.
Wound healing in the patient with diabetes mellitus.
Nurs Clin North Am, 25 (1990), pp. 247-261
[39.]
W. Marhoeffer, M. Stein, E. Maeser, K. Federlin.
Impairment of polymorphonuclear leukolyte function and metabolic control of diabetes.
Diabetes care, 15 (1992), pp. 256-260
[40.]
B. Bissonnette, B.J. Dalens.
Pediatric Anesthesia; principles and practice, Mc Graw-Hill, (2001),
[41.]
Northmpthom Hospital General. Federación Madill de Sociedades de Anestesiología (UK). Dirección clínica de Diabetes Mellitus durante la Anestesia y Cirugía; Disponibles en: URL: www.northamptongeneral.nhswww.diabetes.org.uk
[42.]
A. Peters, W. Kerner.
Perioperative management of the diabetic patient.
Exp Clin Endocrinol Diabetes, 103 (1995), pp. 213
[43.]
M.M. Martin, A.L.A. Martin.
Continuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children.
J Pediatr, 89 (1976), pp. 560-564
[44.]
Intensive diabetes management, 3 ed, pp. 102
[45.]
S.K. Mercker, C. Maier, G. Neumann, H. Wulf.
Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin.
Anesthesiology, 87 (1997), pp. 1003
[46.]
M. Solano, C. González, M. Álvarez, B. Llorente.
Echegaray M.
Acidosis láctica en paciente diabético tratado con metformina. An Med Interna., 21 (2004), pp. 288-290
[47.]
T.M. Hemmerling, M.C. Schmid, J. Schmit, S. Kern, K.E. Jacobi.
Comparison of a continucos glucose-insulin-potassium infusion versus intermitent bolus application of insulin on perioperative glucose control and hormone status in insulin-treated type 2 diabetics.
J Clin Anesth, 13 (2001), pp. 293-300
[48.]
M. Raucoules-Aime, Y. Labib, J. Levraut, P. Gastaud, C. Dolisi, D. Grimaud.
Use of i.v. insulin in well-controlled non-insulin-dependent diabetic undergoing major surgery.
Br J Anaesth, 76 (1996), pp. 198-202
[49.]
L. Gonzalez-Michaca, M. Ahumada, S. Ponce-de-Leon.
Insulin subcutaneous applications vs continuos infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus.
Arch Med Res, 33 (2002), pp. 48-52
[50.]
J.N. Roemmich, P.A. Clark, M. Lusk, A. Friel, A. Weltman, L.H. Epstein.
Pubertal alterations in growth and body composition. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
Int J obes relat metab disord, 26 (2002), pp. 701-709
Copyright © 2011. Revista Colombiana de Anestesiología
Opciones de artículo